{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:13:21Z","timestamp":1757618001824,"version":"3.44.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10072-025-08193-9","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T02:40:24Z","timestamp":1745548824000},"page":"3783-3795","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between information processing speed and clinical features in people with multiple sclerosis and neuromyelitis optica: a comparative study"],"prefix":"10.1007","volume":"46","author":[{"given":"Saeed","family":"Vaheb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5821-5464","authenticated-orcid":false,"given":"Ziba","family":"Rajaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Shaygannejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hojjatallah","family":"Alaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Afshari-Safavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Mirmosayyeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"issue":"7","key":"8193_CR1","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1002\/cti2.1316","volume":"10","author":"JA Lopez","year":"2021","unstructured":"Lopez JA, Denkova M, Ramanathan S, Dale RC, Brilot F (2021) Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis Optica spectrum disorders and Myelin oligodendrocyte glycoprotein antibody-associated disease. Clin Translational Immunol 10(7):e1316","journal-title":"Clin Translational Immunol"},{"issue":"8","key":"8193_CR2","doi-asserted-by":"publisher","first-page":"e0184012","DOI":"10.1371\/journal.pone.0184012","volume":"12","author":"H Masuda","year":"2017","unstructured":"Masuda H, Hirano S, Takahashi N, Hatsugano E, Uzawa A, Uchida T et al (2017) Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis Optica spectrum disorder. PLoS ONE 12(8):e0184012","journal-title":"PLoS ONE"},{"key":"8193_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40120-021-00239-2","volume":"10","author":"L Lakin","year":"2021","unstructured":"Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR (2021) Comprehensive approach to management of multiple sclerosis: addressing invisible symptoms\u2014a narrative review. Neurol Therapy 10:75\u201398","journal-title":"Neurol Therapy"},{"issue":"7","key":"8193_CR4","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","volume":"270","author":"S Jarius","year":"2023","unstructured":"Jarius S, Aktas O, Ayzenberg I, Bellmann-Strobl J, Berthele A, Giglhuber K et al (2023) Update on the diagnosis and treatment of neuromyelits Optica spectrum disorders (NMOSD)\u2013revised recommendations of the neuromyelitis Optica study group (NEMOS). Part I: diagnosis and differential diagnosis. J Neurol 270(7):3341\u20133368","journal-title":"J Neurol"},{"key":"8193_CR5","doi-asserted-by":"publisher","first-page":"103496","DOI":"10.1016\/j.msard.2022.103496","volume":"58","author":"Y Yang","year":"2022","unstructured":"Yang Y, Rui Q, Han S, Wu X, Wang X, Wu P et al (2022) Reduced GABA levels in the medial prefrontal cortex are associated with cognitive impairment in patients with NMOSD. Multiple Scler Relat Disorders 58:103496","journal-title":"Multiple Scler Relat Disorders"},{"issue":"2","key":"8193_CR6","doi-asserted-by":"publisher","first-page":"e3433","DOI":"10.1002\/brb3.3433","volume":"14","author":"Y Duan","year":"2024","unstructured":"Duan Y, Rui Q, Yang Y, Tian J, Cao S, Zhu F et al (2024) Correlation of GABA\u2009+\u2009levels in the medial prefrontal cortex and Circulating follicular helper T cells in neuromyelitis Optica spectrum disorder patients with cognitive impairment. Brain Behav 14(2):e3433","journal-title":"Brain Behav"},{"issue":"6","key":"8193_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1177\/1352458516645869","volume":"23","author":"SL Costa","year":"2017","unstructured":"Costa SL, Genova HM, DeLuca J, Chiaravalloti ND (2017) Information processing speed in multiple sclerosis: past, present, and future. Multiple Scler J 23(6):772\u2013789","journal-title":"Multiple Scler J"},{"issue":"6","key":"8193_CR8","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/ene.14732","volume":"28","author":"MW Koch","year":"2021","unstructured":"Koch MW, Mostert J, Repovic P, Bowen JD, Uitdehaag B, Cutter G (2021) Is the symbol digit modalities test a useful outcome in secondary progressive multiple sclerosis? Eur J Neurol 28(6):2115\u20132120","journal-title":"Eur J Neurol"},{"key":"8193_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12883-015-0296-2","volume":"15","author":"M L\u00f3pez-G\u00f3ngora","year":"2015","unstructured":"L\u00f3pez-G\u00f3ngora M, Querol L, Escart\u00edn A (2015) A one-year follow-up study of the symbol digit modalities test (SDMT) and the paced auditory serial addition test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity. BMC Neurol 15:1\u20138","journal-title":"BMC Neurol"},{"issue":"13","key":"8193_CR10","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1177\/1352458518808204","volume":"25","author":"L Strober","year":"2019","unstructured":"Strober L, DeLuca J, Benedict RH, Jacobs A, Cohen JA, Chiaravalloti N et al (2019) Symbol digit modalities test: a valid clinical trial endpoint for measuring cognition in multiple sclerosis. Multiple Scler J 25(13):1781\u20131790","journal-title":"Multiple Scler J"},{"key":"8193_CR11","doi-asserted-by":"publisher","first-page":"36S","DOI":"10.1177\/1051228404266267","volume":"14","author":"RH Benedict","year":"2004","unstructured":"Benedict RH, Carone DA, Bakshi R (2004) Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 14:36S\u201345S","journal-title":"J Neuroimaging"},{"key":"8193_CR12","doi-asserted-by":"publisher","first-page":"1188124","DOI":"10.3389\/fneur.2023.1188124","volume":"14","author":"RI Spain","year":"2023","unstructured":"Spain RI, Hildebrand A, Waslo CS, Rooney WD, Schwartz DL, Paz Soldan MM et al (2023) Processing speed and memory test performance are associated with different brain region volumes in veterans and others with progressive multiple sclerosis. Front Neurol 14:1188124","journal-title":"Front Neurol"},{"issue":"3","key":"8193_CR13","doi-asserted-by":"publisher","first-page":"e0120754","DOI":"10.1371\/journal.pone.0120754","volume":"10","author":"F Patti","year":"2015","unstructured":"Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D et al (2015) Lesion load May predict long-term cognitive dysfunction in multiple sclerosis patients. PLoS ONE 10(3):e0120754","journal-title":"PLoS ONE"},{"issue":"5","key":"8193_CR14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/jcm9051326","volume":"9","author":"O Mirmosayyeb","year":"2020","unstructured":"Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Sadeghi Bahmani D (2020) Clinical characteristics and disability progression of early-and late-onset multiple sclerosis compared to adult-onset multiple sclerosis. J Clin Med 9(5):1326","journal-title":"J Clin Med"},{"issue":"2","key":"8193_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173","journal-title":"Lancet Neurol"},{"key":"8193_CR16","doi-asserted-by":"crossref","unstructured":"Wingerchuk D, Banwell B, Bennett J, Cabre P, Carroll W, Chitnis T et al (2014) Revised diagnostic criteria for neuromyelitis Optica spectrum disorders (S63. 001). AAN Enterprises","DOI":"10.1212\/WNL.82.10_supplement.S63.001"},{"issue":"3","key":"8193_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ana.25808","volume":"88","author":"M Filippi","year":"2020","unstructured":"Filippi M, Preziosa P, Langdon D, Lassmann H, Paul F, Rovira \u00c0 et al (2020) Identifying progression in multiple sclerosis: new perspectives. Ann Neurol 88(3):438\u2013452","journal-title":"Ann Neurol"},{"key":"8193_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.msard.2019.04.017","volume":"32","author":"N Koch-Henriksen","year":"2019","unstructured":"Koch-Henriksen N, Thygesen LC, S\u00f8rensen PS, Magyari M (2019) Worsening of disability caused by relapses in multiple sclerosis: A different approach. Multiple Scler Relat Disorders 32:1\u20138","journal-title":"Multiple Scler Relat Disorders"},{"issue":"10","key":"8193_CR19","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1177\/1352458511406309","volume":"17","author":"R Nicholas","year":"2011","unstructured":"Nicholas R, Straube S, Schmidli H, Schneider S, Friede T (2011) Trends in annualized relapse rates in relapsing\u2013remitting multiple sclerosis and consequences for clinical trial design. Multiple Scler J 17(10):1211\u20131217","journal-title":"Multiple Scler J"},{"key":"8193_CR20","unstructured":"Han MH (2009) Adams and Victor\u2019s principles of neurology. American Association of Neuropathologists, Inc."},{"issue":"5","key":"8193_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1177\/1352458517690821","volume":"23","author":"RH Benedict","year":"2017","unstructured":"Benedict RH, DeLuca J, Phillips G, LaRocca N, Hudson LD, Rudick R, Consortium MSOA (2017) Validity of the symbol digit modalities test as a cognition performance outcome measure for multiple sclerosis. Multiple Scler J 23(5):721\u2013733","journal-title":"Multiple Scler J"},{"issue":"6","key":"8193_CR22","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/13854046.2012.694912","volume":"26","author":"A Eshaghi","year":"2012","unstructured":"Eshaghi A, Riyahi-Alam S, Roostaei T, Haeri G, Aghsaei A, Aidi MR et al (2012) Validity and reliability of a Persian translation of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). Clin Neuropsychol 26(6):975\u2013984","journal-title":"Clin Neuropsychol"},{"issue":"13","key":"8193_CR23","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1177\/13524585221107125","volume":"28","author":"L Cacciaguerra","year":"2022","unstructured":"Cacciaguerra L, Mistri D, Valsasina P, Martinelli V, Filippi M, Rocca MA (2022) Time-varying connectivity of the precuneus and its association with cognition and depressive symptoms in neuromyelitis Optica: A pilot MRI study. Multiple Scler J 28(13):2057\u20132069","journal-title":"Multiple Scler J"},{"key":"8193_CR24","doi-asserted-by":"publisher","first-page":"904309","DOI":"10.3389\/fnins.2022.904309","volume":"16","author":"Z Yan","year":"2022","unstructured":"Yan Z, Wang X, Zhu Q, Shi Z, Chen X, Han Y et al (2022) Alterations in white matter fiber tracts characterized by automated fiber-tract quantification and their correlations with cognitive impairment in neuromyelitis Optica spectrum disorder patients. Front NeuroSci 16:904309","journal-title":"Front NeuroSci"},{"issue":"3","key":"8193_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","volume":"15","author":"M Filippi","year":"2016","unstructured":"Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15(3):292\u2013303","journal-title":"Lancet Neurol"},{"key":"8193_CR26","doi-asserted-by":"crossref","unstructured":"Hassanzadeh S, Mirmosayyeb O, Bagherieh S, Afshari-Safavi A, Barzegar M, Ghaffary EM, Shaygannejad V (2023) Sociodemographic and neuroimaging evaluation of patients with multiple sclerosis and radiologically isolated syndrome in Isfahan, Iran. Archives Neurosci.;10(3)","DOI":"10.5812\/ans-137025"},{"key":"8193_CR27","unstructured":"Mehta CR, Patel NR (2011) IBM SPSS exact tests. Armonk, NY: IBM Corporation.;23:24"},{"issue":"4","key":"8193_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1474-4422(11)70020-5","volume":"10","author":"AJ Coles","year":"2011","unstructured":"Coles AJ, Fox E, Vladic A, Gazda SK, Brinar V, Selmaj KW et al (2011) Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes. Lancet Neurol 10(4):338\u2013348","journal-title":"Lancet Neurol"},{"issue":"1","key":"8193_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000047940","volume":"47","author":"Y Barak","year":"2002","unstructured":"Barak Y, Achiron A (2002) Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 47(1):11\u201314","journal-title":"Eur Neurol"},{"issue":"8","key":"8193_CR30","doi-asserted-by":"publisher","first-page":"e71058","DOI":"10.1371\/journal.pone.0071058","volume":"8","author":"A Achiron","year":"2013","unstructured":"Achiron A, Chapman J, Magalashvili D, Dolev M, Lavie M, Bercovich E et al (2013) Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study. PLoS ONE 8(8):e71058","journal-title":"PLoS ONE"},{"issue":"11","key":"8193_CR31","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3390\/jpm11111107","volume":"11","author":"E Lopez-Soley","year":"2021","unstructured":"Lopez-Soley E, Martinez-Heras E, Andorra M, Solanes A, Radua J, Montejo C et al (2021) Dynamics and predictors of cognitive impairment along the disease course in multiple sclerosis. J Personalized Med 11(11):1107","journal-title":"J Personalized Med"},{"issue":"2","key":"8193_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14(2):183\u2013193","journal-title":"Lancet Neurol"},{"issue":"2","key":"8193_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/arclin\/acu095","volume":"30","author":"HJ Westervelt","year":"2015","unstructured":"Westervelt HJ (2015) Dementia in multiple sclerosis: why is it rarely discussed? Arch Clin Neuropsychol 30(2):174\u2013177","journal-title":"Arch Clin Neuropsychol"},{"issue":"9","key":"8193_CR34","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/1352458516674367","volume":"23","author":"L Ruano","year":"2017","unstructured":"Ruano L, Portaccio E, Goretti B, Niccolai C, Severo M, Patti F et al (2017) Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes. Multiple Scler J 23(9):1258\u20131267","journal-title":"Multiple Scler J"},{"key":"8193_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/23279095.2019.1624260","volume-title":"Cognitive functions and disability progression in relapsing-remitting multiple sclerosis: A longitudinal study","author":"E Heled","year":"2021","unstructured":"Heled E, Aloni R, Achiron A (2019) Cognitive functions and disability progression in relapsing-remitting multiple sclerosis: A longitudinal study. Adult Appl Neuropsychol. https:\/\/doi.org\/10.1080\/23279095.2019.1624260"},{"key":"8193_CR36","doi-asserted-by":"publisher","first-page":"958441","DOI":"10.3389\/fneur.2022.958441","volume":"13","author":"L Kong","year":"2022","unstructured":"Kong L, Lang Y, Wang X, Wang J, Chen H, Shi Z, Zhou H (2022) Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis Optica spectrum disorder. Front Neurol 13:958441","journal-title":"Front Neurol"},{"key":"8193_CR37","unstructured":"Li J-Y, Xue H-R, Wang L, Zhang M-N, Zhang Y-Y (2023) Relationship of immune cells with disability and cognitive impairment in patients with neuromyelitis Optica spectrum disorder. Eur Rev Med Pharmacol Sci.;27(20)"},{"issue":"6","key":"8193_CR38","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1177\/1352458516665496","volume":"23","author":"M Pitteri","year":"2017","unstructured":"Pitteri M, Romualdi C, Magliozzi R, Monaco S, Calabrese M (2017) Cognitive impairment predicts disability progression and cortical thinning in MS: an 8-year study. Multiple Scler J 23(6):848\u2013854","journal-title":"Multiple Scler J"},{"issue":"3","key":"8193_CR39","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1474-4422(14)70250-9","volume":"14","author":"MA Rocca","year":"2015","unstructured":"Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner I-K et al (2015) Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. Lancet Neurol 14(3):302\u2013317","journal-title":"Lancet Neurol"},{"key":"8193_CR40","doi-asserted-by":"publisher","first-page":"811518","DOI":"10.3389\/fneur.2021.811518","volume":"12","author":"O Perdaens","year":"2022","unstructured":"Perdaens O, Van Pesch V (2022) Molecular mechanisms of immunosenescene and inflammaging: relevance to the Immunopathogenesis and treatment of multiple sclerosis. Front Neurol 12:811518","journal-title":"Front Neurol"},{"issue":"7","key":"8193_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1177\/1545968314521010","volume":"28","author":"I Baert","year":"2014","unstructured":"Baert I, Freeman J, Smedal T, Dalgas U, Romberg A, Kalron A et al (2014) Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabilit Neural Repair 28(7):621\u2013631","journal-title":"Neurorehabilit Neural Repair"},{"issue":"3","key":"8193_CR42","doi-asserted-by":"publisher","first-page":"e0230691","DOI":"10.1371\/journal.pone.0230691","volume":"15","author":"F Foolad","year":"2020","unstructured":"Foolad F, Khodagholi F, Nabavi SM, Javan M (2020) Changes in mitochondrial function in patients with neuromyelitis Optica; correlations with motor and cognitive disabilities. PLoS ONE 15(3):e0230691","journal-title":"PLoS ONE"},{"key":"8193_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00415-019-09643-z","volume":"267","author":"E Tavazzi","year":"2020","unstructured":"Tavazzi E, Bergsland N, Kuhle J, Jakimovski D, Ramanathan M, Maceski AM et al (2020) A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis. J Neurol 267:802\u2013811","journal-title":"J Neurol"},{"issue":"7","key":"8193_CR44","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.neuint.2013.05.003","volume":"63","author":"HE Scharfman","year":"2013","unstructured":"Scharfman HE, Binder DK (2013) Aquaporin-4 water channels and synaptic plasticity in the hippocampus. Neurochem Int 63(7):702\u2013711","journal-title":"Neurochem Int"},{"key":"8193_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00429-011-0373-2","volume":"218","author":"Y Fan","year":"2013","unstructured":"Fan Y, Liu M, Wu X, Wang F, Ding J, Chen J, Hu G (2013) Aquaporin-4 promotes memory consolidation in Morris water maze. Brain Struct Function 218:39\u201350","journal-title":"Brain Struct Function"},{"issue":"1","key":"8193_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ana.23721","volume":"73","author":"E Saji","year":"2013","unstructured":"Saji E, Arakawa M, Yanagawa K, Toyoshima Y, Yokoseki A, Okamoto K et al (2013) Cognitive impairment and cortical degeneration in neuromyelitis Optica. Ann Neurol 73(1):65\u201376","journal-title":"Ann Neurol"},{"issue":"2","key":"8193_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/ene.13224","volume":"24","author":"JW Hyun","year":"2017","unstructured":"Hyun JW, Park G, Kwak K, Jo HJ, Joung A, Kim JH et al (2017) Deep Gray matter atrophy in neuromyelitis Optica spectrum disorder and multiple sclerosis. Eur J Neurol 24(2):437\u2013445","journal-title":"Eur J Neurol"},{"issue":"17","key":"8193_CR48","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1212\/WNL.0000000000002067","volume":"85","author":"Y Liu","year":"2015","unstructured":"Liu Y, Fu Y, Schoonheim MM, Zhang N, Fan M, Su L et al (2015) Structural MRI substrates of cognitive impairment in neuromyelitis Optica. Neurology 85(17):1491\u20131499","journal-title":"Neurology"},{"issue":"1","key":"8193_CR49","first-page":"e311","volume":"4","author":"Y Takeshita","year":"2016","unstructured":"Takeshita Y, Obermeier B, Cotleur AC, Spampinato SF, Shimizu F, Yamamoto E et al (2016) Effects of neuromyelitis optica\u2013IgG at the blood\u2013brain barrier in vitro. Neurology: Neuroimmunol Neuroinflammation 4(1):e311","journal-title":"Neurology: Neuroimmunol Neuroinflammation"},{"key":"8193_CR50","doi-asserted-by":"publisher","first-page":"453373","DOI":"10.3389\/fneur.2019.00608","volume":"10","author":"FC Oertel","year":"2019","unstructured":"Oertel FC, Schlie\u00dfeit J, Brandt AU, Paul F (2019) Cognitive impairment in neuromyelitis Optica spectrum disorders: a review of clinical and neuroradiological features. Front Neurol 10:453373","journal-title":"Front Neurol"},{"key":"8193_CR51","doi-asserted-by":"crossref","unstructured":"Fujimori J, Nakashima I (2024) Brain volume loss in Japanese patients with multiple sclerosis is present in the early to middle stage of the disease. Heliyon.;10(6)","DOI":"10.1016\/j.heliyon.2024.e28136"},{"issue":"7","key":"8193_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1177\/1352458519845109","volume":"26","author":"F Savoldi","year":"2020","unstructured":"Savoldi F, Rocca MA, Valsasina P, Riccitelli GC, Mesaros S, Drulovic J et al (2020) Functional brain connectivity abnormalities and cognitive deficits in neuromyelitis Optica spectrum disorder. Multiple Scler J 26(7):795\u2013805","journal-title":"Multiple Scler J"},{"issue":"9","key":"8193_CR53","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1001\/jamaneurol.2015.1241","volume":"72","author":"DM Harrison","year":"2015","unstructured":"Harrison DM, Roy S, Oh J, Izbudak I, Pham D, Courtney S et al (2015) Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol 72(9):1004\u20131012","journal-title":"JAMA Neurol"},{"issue":"10","key":"8193_CR54","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1093\/brain\/aws246","volume":"135","author":"M Calabrese","year":"2012","unstructured":"Calabrese M, Poretto V, Favaretto A, Alessio S, Bernardi V, Romualdi C et al (2012) Cortical lesion load associates with progression of disability in multiple sclerosis. Brain 135(10):2952\u20132961","journal-title":"Brain"},{"issue":"9","key":"8193_CR55","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","volume":"66","author":"M Calabrese","year":"2009","unstructured":"Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66(9):1144\u20131150","journal-title":"Arch Neurol"},{"issue":"6","key":"8193_CR56","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/1352458509102907","volume":"15","author":"S Roosendaal","year":"2009","unstructured":"Roosendaal S, Moraal B, Pouwels P, Vrenken H, Castelijns J, Barkhof F, Geurts J (2009) Accumulation of cortical lesions in MS: relation with cognitive impairment. Multiple Scler J 15(6):708\u2013714","journal-title":"Multiple Scler J"},{"issue":"11","key":"8193_CR57","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1212\/WNL.0b013e31828726cc","volume":"80","author":"HE Hulst","year":"2013","unstructured":"Hulst HE, Steenwijk MD, Versteeg A, Pouwels PJ, Vrenken H, Uitdehaag BM et al (2013) Cognitive impairment in MS: impact of white matter integrity, Gray matter volume, and lesions. Neurology 80(11):1025\u20131032","journal-title":"Neurology"},{"issue":"1","key":"8193_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/archneurol.2007.16","volume":"65","author":"F Blanc","year":"2008","unstructured":"Blanc F, Z\u00e9phir H, Lebrun C, Labauge P, Castelnovo G, Fleury M et al (2008) Cognitive functions in neuromyelitis Optica. Arch Neurol 65(1):84\u201388","journal-title":"Arch Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08193-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08193-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:36:40Z","timestamp":1757169400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08193-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["8193"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08193-9","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"3 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research adhered to the Declaration of Helsinki\u2019s ethical principles and approved by the Ethics Committee of Isfahan University of Medical Sciences (IR.MUI.MED.REC.1402.459).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}